(Total Views: 743)
Posted On: 02/02/2018 7:05:39 PM
Post# of 1354
NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO Discusses Recent Corporate Milestones in Webinar Update
Pressure BioSciences Inc. (OTCQB: PBIO) CEO Richard T. Schumacher earlier this week hosted a webinar update and live Q&A session for prospective investors. During the presentation, Schumacher detailed each of PBIO’s three distinct working groups, including its Research Products and Services division, its Biopharmaceutical Manufacturing division and its third group specializing in the development and implementation of the company’s cutting-edge Ultra Shear Technology (“UST”) platform. “The company’s really split now into three different working groups. We’ve made an acquisition and we’ve gotten a new patent that’s been approved, all in the last several months, and it’s changed the face of the company a great deal… We’re looking forward to a very very interesting year for Pressure Biosciences,” Schumacher stated during the update. Additional topics discussed during the presentation include the company’s newly-expanded salesforce and its December 2017 acquisition of BaroFold Inc.’s asset portfolio, as well as a brief outlook for the 2018 fiscal year.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences Inc. (OTCQB: PBIO) CEO Richard T. Schumacher earlier this week hosted a webinar update and live Q&A session for prospective investors. During the presentation, Schumacher detailed each of PBIO’s three distinct working groups, including its Research Products and Services division, its Biopharmaceutical Manufacturing division and its third group specializing in the development and implementation of the company’s cutting-edge Ultra Shear Technology (“UST”) platform. “The company’s really split now into three different working groups. We’ve made an acquisition and we’ve gotten a new patent that’s been approved, all in the last several months, and it’s changed the face of the company a great deal… We’re looking forward to a very very interesting year for Pressure Biosciences,” Schumacher stated during the update. Additional topics discussed during the presentation include the company’s newly-expanded salesforce and its December 2017 acquisition of BaroFold Inc.’s asset portfolio, as well as a brief outlook for the 2018 fiscal year.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
